Literature DB >> 24351320

Cancer survival: global surveillance will stimulate health policy and improve equity.

Michel P Coleman1.   

Abstract

Millions of people will continue to be diagnosed with cancer every year for the foreseeable future. These patients all need access to optimum health care. Population-based cancer survival is a key measure of the overall effectiveness of health systems in management of cancer. Survival varies very widely around the world. Global surveillance of cancer survival is needed, because unless these avoidable inequalities are measured, and reported on regularly, nothing will be done explicitly to reduce them.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 24351320     DOI： 10.1016/S0140-6736(13)62225-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  42 in total

1.  Breast cancer control in China: challenges and opportunities of the use of population-based routine data studies.

Authors:  Ana Catarina Pinto; Rita Canário; Paula Fidalgo
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

2.  Population-based cancer survival in the United States: Data, quality control, and statistical methods.

Authors:  Claudia Allemani; Rhea Harewood; Christopher J Johnson; Helena Carreira; Devon Spika; Audrey Bonaventure; Kevin Ward; Hannah K Weir; Michel P Coleman
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

3.  Disparities in breast cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.

Authors:  Jacqueline W Miller; Judith Lee Smith; A Blythe Ryerson; Thomas C Tucker; Claudia Allemani
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

4.  Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland.

Authors:  Miikka Korja; Rahul Raj; Karri Seppä; Tapio Luostarinen; Nea Malila; Matti Seppälä; Hanna Mäenpää; Janne Pitkäniemi
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

5.  Survival of primary lung cancer patients in Brunei Darussalam, 1987-2012.

Authors:  Lin Naing; Amalina Abdullah; Syafiq Abdullah; Nurolaini Kifli
Journal:  Ann Transl Med       Date:  2017-03

6.  Racial-Sex Disparities--A Challenging Battle Against Cancer Mortality in the USA.

Authors:  Wenjiang J Fu
Journal:  J Racial Ethn Health Disparities       Date:  2014-10-02

7.  Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Authors:  Claudia Allemani; Tomohiro Matsuda; Veronica Di Carlo; Rhea Harewood; Melissa Matz; Maja Nikšić; Audrey Bonaventure; Mikhail Valkov; Christopher J Johnson; Jacques Estève; Olufemi J Ogunbiyi; Gulnar Azevedo E Silva; Wan-Qing Chen; Sultan Eser; Gerda Engholm; Charles A Stiller; Alain Monnereau; Ryan R Woods; Otto Visser; Gek Hsiang Lim; Joanne Aitken; Hannah K Weir; Michel P Coleman
Journal:  Lancet       Date:  2018-01-31       Impact factor: 79.321

8.  Adult leukemia survival trends in the United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009.

Authors:  Chris Bailey; Lisa C Richardson; Claudia Allemani; Audrey Bonaventure; Rhea Harewood; Angela R Moore; Sherri L Stewart; Hannah K Weir; Michel P Coleman
Journal:  Cancer       Date:  2018-10-21       Impact factor: 6.860

9.  Five-Year U.S. Trends in the North American Cancer Survival Index, 2005-2014.

Authors:  Bożena M Morawski; Hannah K Weir; Christopher J Johnson
Journal:  Am J Prev Med       Date:  2019-12-10       Impact factor: 5.043

10.  Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.

Authors:  G Curigliano; D Lenihan; M Fradley; S Ganatra; A Barac; A Blaes; J Herrmann; C Porter; A R Lyon; P Lancellotti; A Patel; J DeCara; J Mitchell; E Harrison; J Moslehi; R Witteles; M G Calabro; R Orecchia; E de Azambuja; J L Zamorano; R Krone; Z Iakobishvili; J Carver; S Armenian; B Ky; D Cardinale; C M Cipolla; S Dent; K Jordan
Journal:  Ann Oncol       Date:  2020-02       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.